Analysys of upregulated gene expression of interleukin-15 by synoviocytes in patients with rheumatoid arthritis
Analysys of upregulated gene expression of interleukin-15 by synoviocytes in patients with rheumatoid arthritis
批准号:
12670411
负责人:
AMASAKI Yoshiharu
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
TNFα-TNF receptor signaling is known to play a pivotal role in the promotion of joint destruction in Rheumatoid arthritis (RA). It has been recently reported that Interleukin-15 (IL-15) a newly discovered cytokine largely produced by macrophages, is increased in synovial fluid in RA, and can mediate secretion of TNFα. In current study, upregulated mRNA expression of IL-15 in rheumatoid synoviocytes was investigated by using freshly isolated and cultured synoviocytes from RA or osteoarthritis (OA) patients. mRNA expression analyzes using RT-PCR showed upregulated expression of IL-15 by synoviocytes, not only from RA patients but also from some OA patients. Expression of IL-15 was also observed in both RA and OA synoviocytes at protein levels by using intracellular FACS staining, indicating that IL-15 expression by itself is not specific to RA. When stimulated by TNFα or LPS, both RA and OA synoviocytes showed stimulation dependent upregulation of IL-15 mRNA. Since NF-κB and IRF-1 have been shown to be critical transcription factors in IL-15 mRNA regulation, EMSA analysis using these cis-acting elements from IL-15 promoters was also performed. Upon stimulation by either of TNFα or LPS, increased NF-κB DNA-binding activity was induced while not in IRF-1 DNA-binding. These results suggest that IL15 is not RA-specific inducer of TNFα expression, but enhancer of TNFα gene expression that mutually act through induction of NF-κB activities.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
AMASAKI, Y., KOIKE, T.: "APBSCT in the treatment of autoimmune diseases : Current reviewof achievement and future direction"Inflammation and immunity. 10. 135-141 (2002)
AMASAKI, Y., KOIKE, T.:“APBSCT 治疗自身免疫性疾病:当前成果回顾和未来方向”炎症和免疫。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
ADACHIS, AMASAKI, Y., MIYATAKE, S, ARAI, N, IWATA, M.: "Successive expression and activation of NFAT family members during thymocyte differentiation"J. Biol. Chem.. 275. 14708-14716 (2001)
ADACHIS,AMASAKI,Y.,MIYATAKE,S,ARAI,N,IWATA,M.:“胸腺细胞分化过程中 NFAT 家族成员的连续表达和激活”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
ENDO, T., ODA, A., SATOH, I., HASEYAMA, Y., NISHIO, M., KOIZUMI, K, TAKASHIMA, H., FUJIMOTO, K., AMASAKI. Y., FUJITA, H., KOIKE, T., SAWADA, K.: "Stem cell factor protects c-kit+ human primary erythroid cells from apoptosis."Exp Hematol. 29. 833-41 (2001)
远藤,T.,小田,A.,佐藤,I.,长谷山,Y.,西尾,M.,小泉,K,高岛,H.,藤本,K.,天崎。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
The action of short fatty chain acid on cytokine gene regulation.
-
批准号:14570400
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:AMASAKI Yoshiharu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
-
批准号:2026JJ81631
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:廖思思
-
依托单位:
FMR1基因通过TNF信号通路在下颌骨-髂骨移植微环境中对破骨细胞分化及骨整合的调控机制
-
批准号:JCZRLH202600476
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肿瘤坏死因子(TNFα)配对检测抗体的研发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吉敬
-
依托单位:
自噬相关基因CCl2在颅脑创伤(TBI)中通过TNF信号通路导致神经元损伤的机制研究
-
批准号:2026JJ82489
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贾哲勇
-
依托单位:
基于免疫微环境调控的ICIs治疗恶性肿瘤患者结核病风险机制及 TNF-α/INF-γ调控机制研究
-
批准号:JCZRLH202601148
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
早产儿脑白质损伤的 MRI 影像学特征联合炎症因子组合(IL-6、TNF-α、IL-1β)与神经系统损害关联研究
-
批准号:JCZRLH202601761
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
炎症因子组合(IL-6、TNF-α、IL-1β)动态监测在极低出生体重儿坏死性小肠结肠炎早期预测中的价值研究
-
批准号:JCZRLH202601488
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
龙胆酸A靶向TNF-α调控NF-κB/NLRP3炎性小体减轻肝纤维化的机制研究
-
批准号:2026JJ80905
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭江丽
-
依托单位:
葛根素通过抑制巨噬细胞TNF/NFKB通路发挥抗动脉粥样硬化的作用
-
批准号:2026JJ80326
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:简武
-
依托单位:
红紫素-锰基免疫刺激剂放大ROS及调控STING/TNF-α通路增强黑色素瘤免疫治疗机制研究
-
批准号:2026JJ60558
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈安琪
-
依托单位: